These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33001500)

  • 1. Taking tumour budding to the next frontier - a post International Tumour Budding Consensus Conference (ITBCC) 2016 review.
    Studer L; Blank A; Bokhorst JM; Nagtegaal ID; Zlobec I; Lugli A; Fischer A; Dawson H
    Histopathology; 2021 Mar; 78(4):476-484. PubMed ID: 33001500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential clinical scenarios of tumour budding in colorectal cancer.
    Dawson H; Blank A; Zlobec I; Lugli A
    Acta Gastroenterol Belg; 2019; 82(4):515-518. PubMed ID: 31950807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
    Lugli A; Kirsch R; Ajioka Y; Bosman F; Cathomas G; Dawson H; El Zimaity H; Fléjou JF; Hansen TP; Hartmann A; Kakar S; Langner C; Nagtegaal I; Puppa G; Riddell R; Ristimäki A; Sheahan K; Smyrk T; Sugihara K; Terris B; Ueno H; Vieth M; Zlobec I; Quirke P
    Mod Pathol; 2017 Sep; 30(9):1299-1311. PubMed ID: 28548122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.
    Zlobec I; Bächli M; Galuppini F; Berger MD; Dawson HE; Nagtegaal ID; Lugli A
    Virchows Arch; 2021 Dec; 479(6):1085-1090. PubMed ID: 33843013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour budding in solid cancers.
    Lugli A; Zlobec I; Berger MD; Kirsch R; Nagtegaal ID
    Nat Rev Clin Oncol; 2021 Feb; 18(2):101-115. PubMed ID: 32901132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Budding in Colorectal Carcinoma: Translating a Morphologic Score Into Clinically Meaningful Results.
    Cho SJ; Kakar S
    Arch Pathol Lab Med; 2018 Aug; 142(8):952-957. PubMed ID: 30040461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving tumor budding reporting in colorectal cancer: a Delphi consensus study.
    Haddad TS; Lugli A; Aherne S; Barresi V; Terris B; Bokhorst JM; Brockmoeller SF; Cuatrecasas M; Simmer F; El-Zimaity H; Fléjou JF; Gibbons D; Cathomas G; Kirsch R; Kuhlmann TP; Langner C; Loughrey MB; Riddell R; Ristimäki A; Kakar S; Sheahan K; Treanor D; van der Laak J; Vieth M; Zlobec I; Nagtegaal ID
    Virchows Arch; 2021 Sep; 479(3):459-469. PubMed ID: 33650042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour budding and its clinical implications in gastrointestinal cancers.
    Zlobec I; Berger MD; Lugli A
    Br J Cancer; 2020 Sep; 123(5):700-708. PubMed ID: 32601463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung-a single-center analysis of 354 cases.
    Neppl C; Zlobec I; Schmid RA; Berezowska S
    Mod Pathol; 2020 May; 33(5):802-811. PubMed ID: 31796876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern and Significance of Tumour Budding in Colorectal Carcinomas Using ITBCC Guidelines: a Low Resource Setting Practice Observation.
    Ezenkwa US; Ogun GO; Bamiro OO; Mashor MI; Okolo CA; Adegoke OO; Ogunbiyi OJ
    J Gastrointest Cancer; 2020 Sep; 51(3):1018-1023. PubMed ID: 31970654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
    Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
    Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
    Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
    Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
    Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
    Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologist's perspectives on reporting of tumour budding in colorectal cancer.
    Roya P; Zameer L; Dey D; Datta J; Bardia A; Mishra D
    Ecancermedicalscience; 2021; 15():1337. PubMed ID: 35211206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting of tumor budding in colorectal adenocarcinomas using ×40 objective: A practical approach for resource constrained set-ups.
    Roy P; Datta J; Roy M; Mallick I; Mohandas M
    Indian J Cancer; 2017; 54(4):640-645. PubMed ID: 30082550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
    Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
    Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.
    Ulase D; Heckl S; Behrens HM; Krüger S; Röcken C
    Histopathology; 2020 Feb; 76(3):433-446. PubMed ID: 31538348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should a fourth category be added to the international tumor budding consensus conference tumor budding scoring system in colorectal adenocarcinomas?
    Secinti IE; Ozgur T; Gursoy D; Dede I
    APMIS; 2022 Sep; 130(9):560-567. PubMed ID: 35816469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Tumor Budding Consensus Conference criteria determine the prognosis of oesophageal adenocarcinoma with poor response to neoadjuvant treatment.
    Lohneis P; Rohmann J; Gebauer F; Hieggelke L; Bruns C; Schröder W; Büttner R; Löser H; Quaas A
    Pathol Res Pract; 2022 Apr; 232():153844. PubMed ID: 35316631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma.
    Lohneis P; Hieggelke L; Gebauer F; Ball M; Bruns C; Büttner R; Löser H; Quaas A
    Virchows Arch; 2021 Mar; 478(3):393-400. PubMed ID: 32761393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.